Tag Archive for: Covid-19

Omicron-adapted vaccines will be delivered to the European Union within days of regulatory approval, European member of parliament Peter Liese said on Wednesday.

It is possible to eliminate the monkeypox outbreak in Europe, World Health Organization officials said on Tuesday, highlighting evidence that case counts are slowing in a handful of countries.

German Health Minister Karl Lauterbach said on Wednesday he expects a wave of COVID-19 infections this autumn but ruled out further lockdowns or school closures.

The British scientists behind one of the major therapeutic COVID-19 trials have turned their focus to treatments for monkeypox, a viral disease that has been labeled a global health emergency by the World Health Organization (WHO).

Pending authorization, the Omicron BA.4/BA.5-adapted bivalent vaccine will be available to ship immediately. A conditional marketing authorization application has also been initiated with the European Medicines Agency (EMA) for the Omicron BA.4/BA.5-adapted bivalent vaccine and is expected to be completed in the coming days.

Moderna Inc will supply 12 million doses of its COVID-19 shot adapted to target the Omicron variant of the coronavirus to Canada, the company said on Monday.

Pfizer Inc. Chief Executive Officer Albert Bourla said on Monday he had tested positive for COVID-19 and was experiencing very mild symptoms.

For our 40th Anniversary Edition, we asked our editorial advisory board members to talk about the most significant strides they’ve seen over the course of their careers, how client challenges have changed, thoughts on talent and recruitment strategies, and trends that are advancing the industry. Obviously one of the biggest changes has been the role of digital technology and its part in personalization. But frankly, we barely scratched the surface!

Gilead’s total revenue for Q2 increased 1% to $6.3 billion compared to Q2 in 2021. Overall, the company exceeded both its own expectations and the predictions of market analysts for the second quarter.

The Omicron variant may be more efficient at infecting children through the nose than previous versions of the coronavirus, a small study suggests.